Arcturus Therapeutics's market cap is currently $458.32M. The company's EPS TTM is $-2.213; its P/E ratio is ―; Arcturus Therapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 157.75M	$ 205.75M	$ 12.36M	$ 9.54M	$ 20.79M
Gross Profit	$ 154.79M	$ 62.70M	$ -159.50M	$ -46.41M	$ -11.65M
Operating Income	$ -78.20M	$ 12.18M	$ -202.85M	$ -71.52M	$ -25.51M
EBITDA	$ -24.17M	$ 13.70M	$ -201.66M	$ -70.64M	$ -24.42M
Net Income	$ -29.73M	$ 9.35M	$ -206.86M	$ -71.36M	$ -25.72M
Balance Sheet
Cash & Short-Term Investments	$ 292.00M	$ 391.88M	$ 370.49M	$ 462.89M	$ 71.35M
Total Assets	$ 429.40M	$ 450.39M	$ 392.81M	$ 476.46M	$ 82.14M
Total Debt	$ 30.22M	$ 90.87M	$ 67.61M	$ 17.87M	$ 19.84M
Net Debt	$ -261.79M	$ -301.01M	$ -302.88M	$ -445.02M	$ -51.51M
Total Liabilities	$ 150.89M	$ 180.07M	$ 164.60M	$ 79.90M	$ 56.35M
Stockholders' Equity	$ 278.51M	$ 270.31M	$ 228.21M	$ 396.55M	$ 25.79M
Cash Flow
Free Cash Flow	$ -21.00M	$ 24.27M	$ -138.45M	$ -44.60M	$ -7.26M
Operating Cash Flow	$ -18.10M	$ 31.99M	$ -135.04M	$ -42.86M	$ -6.45M
Investing Cash Flow	$ -2.90M	$ -7.73M	$ -3.41M	$ -1.74M	$ -818.00K
Financing Cash Flow	$ -24.09M	$ -2.86M	$ 48.02M	$ 436.14M	$ 41.91M

Currency in USD

Arcturus Therapeutics Earnings and Revenue History

Income Statement >

Arcturus Therapeutics Debt to Assets

Balance Sheet >

Arcturus Therapeutics Cash Flow

Cash Flow >

Arcturus Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing